{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:51:57Z","timestamp":1787237517214,"version":"build-2736575974"},"reference-count":0,"publisher":"BMJ","issue":"7246","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,5,20]]},"DOI":"10.1136\/bmj.320.7246.1353","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:41:20Z","timestamp":1027752080000},"page":"1353-1354","source":"Crossref","is-referenced-by-count":18,"title":["A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom"],"prefix":"10.1136","volume":"320","author":[{"given":"A.","family":"Streetly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","container-title":["BMJ"],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.320.7246.1353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T19:20:55Z","timestamp":1601061655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.320.7246.1353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5,20]]},"references-count":0,"journal-issue":{"issue":"7246"},"URL":"https:\/\/doi.org\/10.1136\/bmj.320.7246.1353","relation":{},"ISSN":["0959-8138"],"issn-type":[{"value":"0959-8138","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5,20]]}}}